CANY
PRTA icon

Caxton Associates (New York)’s Prothena Corp PRTA Stock Holding History

Caxton Associates (New York)’s Portfolio PRTA Stock Details PRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-13,610
Closed -$165K – 501
2019
Q1 		$165K Buy
+13,610
New +$170K 0.02% 353

Other funds holding PRTA

WIM
Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Caxton Associates (New York)'s PRTA Position: Q2 2019 in Review

Caxton Associates (New York) sold out of Prothena Corp (PRTA) in Q2 2019, closing a stake of 13,610 shares — an estimated $165K sold.

Caxton Associates (New York) first reported a position in PRTA in Q1 2019 and held it in 1 quarter. The position peaked at $165K in Q1 2019. 138 funds tracked by Wall St. Rank hold PRTA as of Q2 2019.

  • Caxton Associates (New York) reported no remaining Prothena Corp position as of Q2 2019 after selling out during the quarter.
  • Caxton Associates (New York) sold 13,610 Prothena Corp shares in Q2 2019, an estimated $165K.
  • Caxton Associates (New York) first reported a position in Prothena Corp in Q1 2019 and held it in 1 quarter.
  • Caxton Associates (New York)'s Prothena Corp position peaked at $165K in Q1 2019.
  • 138 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2019.

Based on Caxton Associates (New York)'s 13F filing for Q2 2019, filed 14 Aug 2019.